Form D · Biotechnology

SYMIC BIOMEDICAL, INC.

San Francisco, CA · CIK 0001592597

Offering snapshot reported Jan 30, 2014 · SEC filing

Reported sold
$1.38M
Offering amount: $1.5M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 8, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$688K$1.38MNov 22, 2013: $850,425.00Nov 22, 2013Jan 30, 2014: $1,375,687.00Jan 30, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$850,425 → $1,375,687
  • Reported investors7 → 16

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 30, 2014Amendment$1,375,687$525,262vs Nov 22, 201316SEC filing
Nov 22, 2013Initial$850,425No comparison7SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-206865

Source: Form D, filed Jan 30, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth N. Horne Director, Executive
John Paderi Director
Alyssa Panitch Director
Kate Stuart Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
953 Indiana Street
San Francisco, CA, 94107